(R)-KRAS G12D inhibitor 28 hydrochloride dihydrate

Name: (R)-KRAS G12D inhibitor 28 hydrochloride dihydrate
Brand: MedChemExpress
SKU: HY-172626A
Rating: 4.5 (0 reviews)

Cat. No.: HY-172626A Purity: 99.58%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

(R)-KRAS G12D inhibitor 28 hydrochloride dehydrate is the hydrochloride dehydrate of (R)-KRAS G12D inhibitor 28 (HY-172626). KRAS G12D inhibitor 28 (Compound 2) is a KRAS G12D inhibitor. KRAS G12D inhibitor 28 (Compound 2) can be used in the cancer research.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

(R)-KRAS G12D inhibitor 28 hydrochloride dihydrate 화학구조

CAS No. : 3081520-70-6

사이즈	재고	수량
1 mg	해외재고보유	Estimated Time of Arrival: December 31
5 mg	해외재고보유	Estimated Time of Arrival: December 31
10 mg	해외재고보유	Estimated Time of Arrival: December 31
50 mg	견적 받기
100 mg	견적 받기

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 Customer Validation

Other Forms of (R)-KRAS G12D inhibitor 28 hydrochloride dihydrate:

KRAS G12D inhibitor 28 견적 받기

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Ras Isoform Specific Products:

View All Isoforms

K-Ras H-Ras N-Ras Ras

Biological Activity
순도&문서
References
고객리뷰

제품 설명

IC₅₀ & Target^[1]

KRas G12D

분자량

701.06

화학식

C₃₅H₃₇Cl₃FN₅O₃

CAS No.

3081520-70-6

Appearance

Solid

Color

White to off-white

SMILES

ClC1=CC=C[C@@]([C@@]2=C(F)C(N=C(C)C3=C4N([C@H]5[C@H]6CN[C@@H]5C6)C([C@@H]7N(C(C8CC8)=O)[C@H]9[C@H](C9)C7)=C3)=C4C=C2CCC#N)=C1Cl.Cl.O.O

선적

Room temperature in continental US; may vary elsewhere.

보관

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

용액&용해도

In Vitro:

DMSO : 100 mg/mL (142.64 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.4264 mL	7.1321 mL	14.2641 mL
5 mM	0.2853 mL	1.4264 mL	2.8528 mL
10 mM	0.1426 mL	0.7132 mL	1.4264 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

몰농도 계산기
농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.5 mg/mL (3.57 mM); Clear solution; Need ultrasonic

This protocol yields a clear solution of 2.5 mg/mL.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (3.57 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (3.57 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

순도&문서

Purity: 99.58%

Select Batch:

Data Sheet (280 KB) SDS (252 KB)

COA (263 KB) HNMR (510 KB) RP-HPLC (266 KB) MS (69 KB)

Handling Instructions (2659 KB)

References

[1]. Jiemin HU, et al. Crystalline forms of 3-(1-(( 1 r,4r,5s)-2-azabicyclo[2.1.1 ]hexan-5-yl)-2-(( 1 r,3r,5r)-2-( cyclopropanecarbonyl)-2-azabicyclo[3.1.0]hexan-3-yl)-7-(2,3-dichlorophenyl)-6-fluoro-4-methyl-1 h-pyrrolo[3,2-c]quinolin-8-yl)propanenitrile.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.4264 mL	7.1321 mL	14.2641 mL	35.6603 mL
	5 mM	0.2853 mL	1.4264 mL	2.8528 mL	7.1321 mL
	10 mM	0.1426 mL	0.7132 mL	1.4264 mL	3.5660 mL
	15 mM	0.0951 mL	0.4755 mL	0.9509 mL	2.3774 mL
	20 mM	0.0713 mL	0.3566 mL	0.7132 mL	1.7830 mL
	25 mM	0.0571 mL	0.2853 mL	0.5706 mL	1.4264 mL
	30 mM	0.0475 mL	0.2377 mL	0.4755 mL	1.1887 mL
	40 mM	0.0357 mL	0.1783 mL	0.3566 mL	0.8915 mL
	50 mM	0.0285 mL	0.1426 mL	0.2853 mL	0.7132 mL
	60 mM	0.0238 mL	0.1189 mL	0.2377 mL	0.5943 mL
	80 mM	0.0178 mL	0.0892 mL	0.1783 mL	0.4458 mL
	100 mM	0.0143 mL	0.0713 mL	0.1426 mL	0.3566 mL